1.Clinical analysis of the efficacy of surgical treatment of gestational trophoblastic disease.
Mi Ran KIM ; Jae Keun JUNG ; Yong Il KWON ; Kyung Hoon LEE ; Chang Joo KIM ; Seung Jo KIM
Journal of the Korean Cancer Association 1993;25(5):680-686
No abstract available.
Gestational Trophoblastic Disease*
2.Changes of sexual behavior after radical hysterectomy.
Yong Hoon CHEE ; Won LEE ; Jae Keun CHUNG ; Dae Hoon KIM ; Do Kang KIM ; Sung Eun NAMKOONG ; Seung Jo KIM
Korean Journal of Obstetrics and Gynecology 1991;34(1):53-62
No abstract available.
Hysterectomy*
;
Sexual Behavior*
3.Pulmonary Vein to Esophageal Fistula after Staged Hybrid Totally Thoracoscopic Surgical and Percutaneous Radiofrequency Catheter Ablation: A Case Report.
Byung Jo PARK ; Yong Han KIM ; Dong Seop JEONG ; Yong Soo CHOI ; Young Keun ON
The Korean Journal of Thoracic and Cardiovascular Surgery 2014;47(6):560-562
A case of a fistula running from the pulmonary vein to the esophagus after a staged hybrid procedure combining total thoracoscopic ablation and percutaneous radiofrequency catheter ablation has not been reported previously. We describe such a case in a 37-year-old man who was successfully treated by surgery.
Adult
;
Catheter Ablation*
;
Esophageal Fistula*
;
Esophagus
;
Fistula
;
Humans
;
Pulmonary Veins*
;
Running
4.A case of pheochromocytoma with electrocardiographic changes mimicking angina pectoris, and hypotensive crises.
Tae Ho JUNG ; Jae Kwon JANG ; Hong Su JUNG ; Sung Kee KIM ; Jong Woon AN ; Kyung Ho JANG ; Yong Keun JO ; Yong Koo OH
Korean Journal of Medicine 1993;45(6):801-807
No abstract available.
Angina Pectoris*
;
Electrocardiography*
;
Pheochromocytoma*
5.Surgical management of metastatic lung cancer from gestational choriocarcinoma.
Jin Yong JEONG ; Woong CHIN ; Kuhn PARK ; Keon Hyon JO ; Young Pil WANG ; Moon Sub KWACK ; Se Wha KIM ; Hong Kyun LEE ; Jae Keun JUNG
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(10):1005-1010
No abstract available.
Choriocarcinoma*
;
Female
;
Lung Neoplasms*
;
Lung*
;
Pregnancy
6.Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.
In Kyu LEE ; Keun Yong PARK ; Hyun Kyung OH ; Rang Woon PARK ; Joon Seung JO
Journal of Korean Medical Science 1994;9(4):341-346
In diabetes mellitus, thickening of basement membrane in capillaries and small vessels is a well-known finding and important in the progression of diabetic microangiopathy. We evaluated whether the plasma levels of type IV collagen and fibronectin, which are important factors of basement membrane, are related with the presence of diabetic microangiopathy. Plasma type IV collagen and fibronectin levels were measured in 40 healthy controls (Mean +/- SD, age; 50.3 +/- 5.5 yr) and 94 diabetic patients (age; 52.4 +/- 13.5 yr) with and without microvascular complications. The mean plasma levels of type IV collagen (5.3 +/- 2.9 ng/ml) and fibronectin (474.4 +/- 119.4 ug/ml) in diabetic patients were significantly higher (p < 0.01) than in healthy controls (3.7 +/- 1.3 ng/ml and 319 +/- 50.9 ug/ml). The mean plasma level of type IV collagen in diabetic patients with complications (6.6 +/- 3.7 ng/ml) was significantly higher (p < 0.01) than in those without complications (4.3 +/- 1.7 ng/ml) and became higher in more complicated patients. Furthermore, the severity of retinopathy and several indicators of nephropathy such as serum BUN, creatinine and proteinuria were closely associated with plasma type IV collagen level and a significant correlation was found between plasma type IV collagen and creatinine clearance (r = -0.31, p < 0.001). There was no significant difference in plasma fibronectin concentrations, however, between the diabetic patients with complications and those without complications.(ABSTRACT TRUNCATED AT 250 WORDS)
Adult
;
Aged
;
Biological Markers/blood
;
Blood Proteins/urine
;
Blood Urea Nitrogen
;
Collagen/*blood
;
Creatinine/blood
;
Diabetic Angiopathies/*blood/diagnosis
;
Diabetic Nephropathies/blood/diagnosis
;
Diabetic Retinopathy/blood/diagnosis
;
Female
;
Fibronectins/*blood
;
Human
;
Male
;
Middle Age
7.Effects of gonadotropin-releasing hormone and gonadal steroids on various hormones secretion in trophoblast cells.
Yong Hun CHEE ; Jin Woo KIM ; Gu Taek HAN ; Jae Keun JUNG ; Dae Hoon KIM ; Sung Eun NAMKOONG ; Seung Jo KIM ; Hun Young LEE
Korean Journal of Obstetrics and Gynecology 1992;35(12):1768-1778
No abstract available.
Gonadotropin-Releasing Hormone*
;
Gonads*
;
Steroids*
;
Trophoblasts*
8.In vivo and in vitro effect of hCG on the activites of mouse macrophage.
Kwang Eun CHOI ; Mi Ran KIM ; Yong Il KWON ; Ki Sung RYU ; Jae Keun JUNG ; Sung Eun NAMKOONG ; Hun Young LEE ; Seung Jo KIM
Korean Journal of Obstetrics and Gynecology 1993;36(2):235-240
No abstract available.
Animals
;
Macrophages*
;
Mice*
9.Thrombolytic Treatment of Prosthetic Valve Thrombosis.
Yong Min KIM ; Yong Whi PARK ; Ju Yup HAN ; Dong Heon YANG ; Young Bae SEO ; Hun Sik PARK ; Yong Keun JO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Journal of the Korean Society of Echocardiography 2001;9(1):38-44
BACKGROUND: Prosthetic valve thrombosis is an uncommon but serious complication. Thrombolytic therapy has recently been proposed as an alternative to surgical methods in treating this condition and is used increasingly. However, the indications for thrombolytic treatment in prosthetic valve thrombosis have not been well defined and differential diagnosis of thrombosis is still difficult. METHODS: Four symptomatic patients with prosthetic valve thrombosis underwent 9 thrombolytic sessions for 7 distinct episodes. Transthoracic or transesophageal echocardiography and cinefluoroscopy were performed and repeated after each thrombolytic session. Urokinase or rt-PA (recombinant tissue-type plasminogen activator) was used and repeated dose was given if necessary. Recurrent thrombosis was treated also either with urokinase or rt-PA. RESULTS: All patients were female and mean age was 38.5 years old. Two valves were in mitral position and the other two were in tricuspid position. The anticoagulation status was inadequate in three patients. The initial success after first dose was 43% (3/7), which increased to 54% (4/7) after repeated thrombolytic therapy. Thrombolytic therapy was failed in three episodes; two thromboses and one ingrowths of pannus. Operations were needed in these cases. No complication was seen. CONCLUSION: Thrombolytic treatment can be used as an alternative to surgical therapy with a low risk of complications. But guideline of thrombolytic therapy for the recurrent thrombosis and education for the patients about the adequate anticoagulation were needed.
Diagnosis, Differential
;
Echocardiography, Transesophageal
;
Education
;
Female
;
Humans
;
Plasminogen
;
Thrombolytic Therapy
;
Thrombosis*
;
Urokinase-Type Plasminogen Activator
10.Changes in Heart Rate during and after Exercise Treadmill Test as Prognostic Factor in Cardiovascular Disease.
Hyung Seop KIM ; Ju Hwan LEE ; Yong Seop KWON ; Hyun Sang LEE ; Dong Hun YANG ; Hun Sik PARK ; Yong Keun JO ; Shung Chull CHAE ; Jae Eun JUN ; Wee Hyun PARK
Korean Circulation Journal 2004;34(2):170-177
BACKGROUND AND OBJECTIVES: Many studies have established risk factors for cardiovascular diseases. The Duke treadmill score has gained widespread acceptance for prognosis and diagnosis in cardiac diseases. Recently, changes in heart rate during and after exercise have also been studied to predict the prognosis of cardiac diseases. We examined the relationship between the incidence of cardiovascular events and exercise capacity, achievement of 85% maximal predicted heart rate (MPHR) or heart rate recovery (HRR) after a routine exercise treadmill test. SUBJECTS AND METHODS: We studied 88 patients with chest pain who were over the age of 30. They were referred for exercise treadmill test for assessment of chest pain and underwent symptom-limited, exercise test with a cool down period of 30 seconds. HRR was defined as the difference in heart rate between peak exercise and 1 minute after exercise. Delta heart rate (DHR) was defined as the difference in heart rate between resting and peak exercise. Other parameters in the exercise test were also measured. RESULTS: Cardiovascular events were found in 13 of the 88 patients. In the events group, age, peak heart rate in exercise, ST depression, maximal exercise capacity, HRR, DHR and achievement of 85% MPHR were all significant variables. There was a favorable prognosis in the patients with a value of HRR >22 beats/minute and a value of DHR >83 beats/minute. Even after adjusting for age, sex, ST depression and left ventricular hypertrophy, the parameters of maximal exercise capacity, HRR, DHR, and achievement of 85% MPHR remained predictive prognostic factors in cardiovascular events. CONCLUSION: Parameters in exercise treadmill test, such as maximal exercise capacity, HRR, DHR and achievement of 85% MPHR, appear to provide additional information and are important variables associated with the prediction of risk in cardiac events.
Cardiovascular Diseases*
;
Chest Pain
;
Depression
;
Diagnosis
;
Exercise Test*
;
Heart Diseases
;
Heart Rate*
;
Heart*
;
Humans
;
Hypertrophy, Left Ventricular
;
Incidence
;
Prognosis
;
Risk Factors